Does RILMENIDINE Cause Hyperleukocytosis? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hyperleukocytosis have been filed in association with RILMENIDINE. This represents 0.7% of all adverse event reports for RILMENIDINE.
6
Reports of Hyperleukocytosis with RILMENIDINE
0.7%
of all RILMENIDINE reports
5
Deaths
6
Hospitalizations
How Dangerous Is Hyperleukocytosis From RILMENIDINE?
Of the 6 reports, 5 (83.3%) resulted in death, 6 (100.0%) required hospitalization, and 6 (100.0%) were considered life-threatening.
Is Hyperleukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RILMENIDINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does RILMENIDINE Cause?
Acute kidney injury (214)
Lactic acidosis (121)
Fall (120)
Hyperkalaemia (86)
Hypotension (85)
Hypoglycaemia (59)
Diarrhoea (49)
Bradycardia (45)
Rhabdomyolysis (44)
Drug ineffective (41)
What Other Drugs Cause Hyperleukocytosis?
CYCLOPHOSPHAMIDE (55)
PREDNISONE (54)
TRETINOIN (52)
ARSENIC TRIOXIDE (49)
RITUXIMAB (49)
ACETAMINOPHEN (44)
VINCRISTINE (44)
DEXAMETHASONE (42)
PANTOPRAZOLE (38)
AMOXICILLIN (36)
Which RILMENIDINE Alternatives Have Lower Hyperleukocytosis Risk?
RILMENIDINE vs RILONACEPT
RILMENIDINE vs RILPIVIRINE
RILMENIDINE vs RILUZOLE
RILMENIDINE vs RIMABOTULINUMTOXINB
RILMENIDINE vs RIMEGEPANT